ANAB R&D to Revenue

Anaptysbio Inc · R&D to Revenue

ANAB logo

ANAB R&D to Revenue

Latest reported57.96%
ANAB FY R&D/Revenue (160.86% → 57.96%)
High-resolution chart · PNG

ANAB r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Anaptysbio Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
57.9575%
179.4917%
813.7903%
863.206%
155.9098%
106.7%
1,241.725%
1,125.92%
309.43%
135.573%
98.4805%
54.3882%
160.8608%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.